NIH: Alcohol addiction depends on gene combination

Drug Discovery |  News | By BioSpectrum Bureau  | 0 Comment | 05 Aug, 2013

Singapore: An experimental treatment for alcohol dependence works better in individuals who possess specific combination...Read more

Merck partners with Kenya research centre

Drug Discovery |  News | By BioSpectrum Bureau  | 0 Comment | 30 Oct, 2014

Singapore: Merck has partnered with Kenya Medical Research Institution (KEMRI) for scientific research and development p...Read more

Shionogi partners with six Irish universities

Drug Discovery |  News | By BioSpectrum Bureau  | 0 Comment | 19 Jun, 2013

Singapore: Shionogi, one of Japan's biggest pharmaceutical companies, has signed a memorandum of understanding (MoU) for...Read more

Merck alzheimer's trial is a success

Drug Discovery |  News | By BioSpectrum Bureau  | 0 Comment | 16 Jul, 2013

Singapore: Merck, which is known as MSD outside the US and Canada, revealed positive results from its phase Ib study sho...Read more

Viralytics multi-cancer drug shows +ve results

Drug Discovery |  News | By BioSpectrum Bureau  | 0 Comment | 09 Apr, 2013

Singapore: Viralytics has finalized the clinical study report on the phase I evaluation of Cavatak, which is administere...Read more

Forest to acquire rights to Merck's Saphris

Drug Discovery |  News | By BioSpectrum Bureau  | 0 Comment | 05 Dec, 2013

Singapore: US based Forest Laboratories plans to acquire exclusive rights in the United States for Saphris (asenapine) s...Read more

FDA approves GSK meningococcal vaccine

Drug Discovery |  News | By BioSpectrum Bureau  | 0 Comment | 15 Jun, 2012

Singapore: The US Food and Drug Administration (FDA) has approved GlaxoSmithKline's vaccine MenHibrix (meningococcal gr...Read more

Patrys gets 2nd Aus patent for cancer drug

Drug Discovery |  News | By BioSpectrum Bureau  | 0 Comment | 19 Nov, 2013

Singapore: Australia-based Patrys, a clinical stage biotechnology company, has been granted a second Australian patent f...Read more

BMS to develop novel therapies for Parkinsons' disease

Drug Discovery |  News | By BioSpectrum Bureau  | 0 Comment | 25 Sep, 2012

Singapore: Vanderbilt University, US, and Bristol-Myers Squibb signed a collaboration agreement for the R&D and comm...Read more

Glenmark receives two ANDA approvals from the FDA

Drug Discovery |  News | By BioSpectrum Bureau  | 0 Comment | 29 Mar, 2016

Glenmark Pharmaceuticals USA (Glenmark) has been granted final approval by the United States Food and Drug Administratio...Read more

Researchers working on new drug for Lupus

Drug Discovery |  Analysis | By BioSpectrum Bureau  | 0 Comment | 20 Jul, 2012

Singapore: It has taken the lupus research community over 50 years to produce a new therapy. Although it is now a year o...Read more

Stem cell therapy effective in liver cirrhosis

Drug Discovery |  News | By BioSpectrum Bureau  | 0 Comment | 04 Jul, 2012

Singapore: A study conducted by Beike Biotechnology Company in conjunction with physicians and researchers at two Chines...Read more

Old drug gives hope for new treatment in autism

Drug Discovery |  News | By BioSpectrum Bureau  | 0 Comment | 15 Mar, 2013

Singapore: Autism results from abnormal cell communication. Testing a new theory, researchers at the University of Calif...Read more

Boehringer, Swiss institute collaborate on diabetes and obesity research

Drug Discovery |  News | By BioSpectrum Bureau  | 0 Comment | 07 Sep, 2012

Singapore: Boehringer Ingelheim and the Institute of Molecular Health Science and the Institute of Food, Nutrition and H...Read more

Omega-3 can reduce brain problems after stroke

Drug Discovery |  News | By BioSpectrum Bureau  | 0 Comment | 22 Feb, 2013

Singapore: A new study by researchers at Columbia University Medical Center, US, revealed that injection of triglyceride...Read more

KHK advances DsiRNA cancer target, pays $5 mn

Drug Discovery |  News | By BioSpectrum Bureau  | 0 Comment | 04 Jan, 2013

Singapore: Dicerna Pharmaceuticals, a RNA interference (RNAi) company focused on developing breakthrough oncology thera...Read more

Celgene halts phase III trial of cancer drug Revlimid

Drug Discovery |  Regulatory | By BioSpectrum Bureau  | 0 Comment | 19 Jul, 2013

Singapore: Celgene has discontinued treatment with Revlimid (lenalidomide), prescribed for for multiple myeloma, in open...Read more

BMS seeks Hep C therapy approval in Japan

Drug Discovery |  News | By BioSpectrum Bureau  | 0 Comment | 07 Nov, 2013

Singapore: Bristol-Myers Squibb has submitted a New Drug Application (NDA) to Japan's Pharmaceutical and Medical Devices...Read more